Archives for January 13, 2009

← 2009

Adventrx cuts its workforce again

By Gareth Macdonald

US drugmaker Adventrx Pharmaceuticals is reducing its workforce to just 14 employees in a bid to preserve cash and refocus efforts on bioequivalence programmes for its lead candidates.

Patheon seeks help to analyse takeover bid

By Phil Taylor

There is still no formal offer on the table for Canadian contract manufacturer Patheon from JLL Patheon Holdings, an investment group which currently owns around 29 per cent of the firm.

Kendle follows peers with cut in ‘08 outlook

By Phil Taylor

Cincinatti, US-based clinical research organization Kendle has cut back its revenue expectations for 2008, primarily as a result of the strengthening of the US dollar, in common with some of its peers in the CRO sector.

Wyeth partners with Santaris on RNA development

By Nick Taylor

Wyeth Pharmaceuticals is continuing efforts to improve its capabilities in the formulation and delivery of RNA through a strategic partnership with Santaris Pharma.

HHS slams FDA for lack of financial oversight during trials

By Gareth Macdonald

A US HHS report on FDA oversight during trials has found that, with current procedures, the agency cannot tell whether drugmakers are disclosing complete financial information from all investigators who worked on a particular study.

Sanofi licenses contract management software

By Nick Taylor

Sanofi-Aventis Canada has licensed I-many’s suite of software for managing pharmaceutical contracts, with the IT company also performing installation, maintenance and support.